4.6 Article

Cutting Edge: B Cell-Intrinsic T-bet Expression Is Required To Control Chronic Viral Infection

Journal

JOURNAL OF IMMUNOLOGY
Volume 197, Issue 4, Pages 1017-1022

Publisher

AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.1500368

Keywords

-

Categories

Funding

  1. NIAID NIH HHS [R01 AI061699, R01 AI113365, P01 AI112521, U19 AI082630, U19 AI117950, P01 AI108545, R01 AI118862, T32 AI007632, R01 AI105343, U01 AI095608, R01 AI076458] Funding Source: Medline

Ask authors/readers for more resources

The role of Ab and B cells in preventing infection is established. In contrast, the role of B cell responses in containing chronic infections remains poorly understood. IgG2a (IgG1 in humans) can prevent acute infections, and T-bet promotes IgG2a isotype switching. However, whether IgG2a and B cell-expressed T-bet influence the host-pathogen balance during persisting infections is unclear. We demonstrate that B cell-specific loss of T-bet prevents control of persisting viral infection. T-bet in B cells controlled IgG2a production, as well as mucosal localization, proliferation, glycosylation, and a broad transcriptional program. T-bet controlled a broad antiviral program in addition to IgG2a because T-bet in B cells was important, even in the presence of virus-specific IgG2a. Our data support a model in which T-bet is a universal controller of antiviral immunity across multiple immune lineages.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available